Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | 90.2B | 96.5B | 88.3B | 84.7B |
| Cost of revenue | 36.4B | 40.6B | 36.5B | 35.5B |
| Gross profit | 53.9B | 55.9B | 51.8B | 49.2B |
| Operating expense | ||||
| Research & development | 13.6B | 13.1B | 12.4B | 11.9B |
| Selling general and admin | 9.7B | 11.8B | 10.8B | 10.0B |
| Other operating expenses | — | — | — | — |
| Operating income | 30.6B | 31.0B | 28.5B | 27.4B |
| Non operating interest income | ||||
| Income | 1.0B | 1.1B | 1.2B | 1.1B |
| Expense | 34M | 53M | 54M | 67M |
| Other income expense | 10.2B | 236M | 2.0B | -897M |
| Pretax income | 41.8B | 32.2B | 31.7B | 27.6B |
| Tax provision | 7.2B | 5.7B | 5.4B | 3.9B |
| Net income | 34.5B | 26.5B | 26.3B | 23.6B |
| Basic EPS | 82.4 | 62.9 | 62.1 | 55.4 |
| Diluted EPS | 81.5 | 62.4 | 61.5 | 54.8 |
| Basic average shares | 420.1M | 421.7M | 423.8M | 425.6M |
| Diluted average shares | 423.8M | 425.8M | 428.2M | 430.9M |
| EBITDA | 36.5B | 36.6B | 33.7B | 32.5B |
| Net income from continuing op. | 34.5B | 26.5B | 26.3B | 23.6B |
| Minority interests | — | — | — | — |
| Preferred stock dividends | — | — | — | — |